Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications

Chunlei Liu, Hongjiang Wei, Nan‐Jie Gong, Matthew J. Cronin, Russel Dibb, Kyle DeckerTomography 2015 · DOI

TL;DR

Quantitative Susceptibility Mapping (QSM) is a powerful MRI technique that quantifies magnetic susceptibility within tissues, offering a direct window into molecular composition and cellular architecture. This review highlights QSM's mechanisms, its ability to differentiate biomaterials like iron and calcium, and its growing clinical applications in areas such as neurodegenerative diseases and brain development.

What Problem Does This Paper Address?

Magnetic Resonance Imaging (MRI) traditionally relies on signal magnitude to create images, but this can be ambiguous when different tissues or substances have similar signal intensities. The phase of the MRI signal, however, is sensitive to local magnetic field variations caused by differences in magnetic susceptibility. This paper addresses the challenge of extracting meaningful, quantitative information about magnetic susceptibility from MRI phase data. Specifically, it aims to explain how Quantitative Susceptibility Mapping (QSM) can overcome the limitations of traditional MRI by providing a more direct and sensitive measure of tissue composition and structure, and to review its diverse applications in characterizing both normal and pathological biological tissues.

Methods

QSM works by first acquiring Gradient-Recalled Echo (GRE) MRI data, from which both magnitude and phase images are obtained. The phase image is then processed through several steps:

  • Masking: A mask of the region of interest (e.g., the brain) is created from the magnitude image to isolate the relevant data.
  • Unwrapping: Phase wrapping, an artifact where phase values cycle between -π and +π, is corrected using algorithms like path-based or Laplacian-based unwrapping.
  • Background Field Removal: External magnetic field inhomogeneities (e.g., from air-tissue interfaces) are removed using techniques such as projection onto dipole fields (PDF) or SHARP processing.
  • Inversion: The core of QSM involves solving an "inverse problem." The measured magnetic field perturbation (derived from the processed phase data) is deconvolved with a dipole kernel. This process aims to recover the underlying magnetic susceptibility distribution. This inversion is mathematically ill-posed due to zeros in the dipole kernel, requiring regularization techniques (e.g., L1 or L2 norms) or advanced methods like multiple-orientation sampling (COSMOS) to obtain stable and accurate results.

The paper also discusses Susceptibility Tensor Imaging (STI), an extension of QSM that accounts for anisotropic susceptibility (where susceptibility varies with direction), particularly relevant for ordered structures like myelin. STI uses data acquired at multiple orientations to reconstruct a susceptibility tensor, enabling more detailed microstructural analysis.

Datasets

This paper is a review article and does not present new experimental data or datasets. It synthesizes findings from numerous previously published studies that utilized various MRI scanners and datasets, often involving human and animal subjects.

Key Insights and Ideas

  • Phase is Key: The phase of the MRI signal, often discarded or minimally processed in standard MRI, holds crucial information about magnetic susceptibility.
  • Direct Molecular Insight: Magnetic susceptibility is directly related to the molecular composition of tissues (e.g., iron, myelin, calcium), offering a more fundamental contrast mechanism than signal intensity alone.
  • Ill-Posed Problem, Clever Solutions: The mathematical challenge of reconstructing susceptibility from phase data is significant, but various sophisticated algorithms (e.g., MEDI, COSMOS, L1/L2 regularization) have been developed to overcome it.
  • Anisotropy Matters: For highly ordered structures like white matter myelin, susceptibility is not uniform in all directions (anisotropic), necessitating techniques like STI for a complete picture.
  • Clinical Potential is Vast: QSM is not just a research tool; it's showing promise in diagnosing and monitoring a wide range of diseases and developmental processes.

Key Results

The paper highlights the qualitative and quantitative advantages of QSM across various applications:

  • Improved Contrast: QSM provides better contrast-to-noise ratios for certain tissues compared to magnitude images, particularly for differentiating biomaterials.
  • Hemorrhage Detection: QSM can accurately measure hemorrhage volumes and differentiate calcifications from paramagnetic materials like hemosiderin, overcoming blooming artifacts seen in T2*-weighted imaging.
  • Brain Development: QSM can track myelination changes during brain development, showing paramagnetic properties in early stages that become diamagnetic as myelin matures.
  • Aging and Neurodegeneration: QSM reveals age-related iron accumulation in deep gray matter and shows promise in identifying iron dysregulation in Parkinson's disease and Alzheimer's disease.
  • Multiple Sclerosis: QSM can help characterize iron deposition in deep gray matter lesions and potentially white matter changes in MS.
  • Oxygenation Imaging: QSM can be used to estimate oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen (CMRO2), offering insights into cerebral physiology.

Limitations and Future Work

  • Computational Complexity: While progress has been made, solving the inverse problem for QSM can still be computationally intensive, especially for whole-brain coverage at high resolutions.
  • Algorithm Dependence: The choice of QSM algorithm can influence the results, and a comprehensive comparison of different algorithms is still needed.
  • Motion Artifacts: For body imaging, motion remains a significant challenge for QSM.
  • Clinical Translation Hurdles: The primary barrier to widespread clinical adoption is the lack of integrated QSM algorithms in commercial MRI scanners, as well as the need for standardized protocols.
  • Future Directions: The authors suggest further research into optimizing QSM for faster scanning, improving its application in body imaging, and conducting larger clinical studies to validate its role as a biomarker for various diseases. The integration of QSM with other imaging modalities and the development of more robust and user-friendly algorithms are also key areas for future work.

Summary updated

Abstract

Quantitative susceptibility mapping (QSM) is a recently developed MRI technique for quantifying the spatial distribution of magnetic susceptibility within biological tissues. It first uses the frequency shift in the MRI signal to map the magnetic field profile within the tissue. The resulting field map is then used to determine the spatial distribution of the underlying magnetic susceptibility by solving an inverse problem. The solution is achieved by deconvolving the field map with a dipole field, under the assumption that the magnetic field is a result of the superposition of the dipole fields generated by all voxels and that each voxel has its unique magnetic susceptibility. QSM provides improved contrast to noise ratio for certain tissues and structures compared to its magnitude counterpart. More importantly, magnetic susceptibility is a direct reflection of the molecular composition and cellular architecture of the tissue. Consequently, by quantifying magnetic susceptibility, QSM is becoming a quantitative imaging approach for characterizing normal and pathological tissue properties. This article reviews the mechanism generating susceptibility contrast within tissues and some associated applications.
BibTeX
@inproceedings{liu2015quantitative,
  author = {Chunlei Liu and Hongjiang Wei and Nan‐Jie Gong and Matthew J. Cronin and Russel Dibb and Kyle Decker},
  title = {{Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications}},
  booktitle = {Tomography},
  year = {2015},
  doi = {10.18383/j.tom.2015.00136},
}
Figure